Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;24(4):202-207.
doi: 10.5152/ThoracResPract.2023.22111.

Association of IL-17F Gene Polymorphism and Its Serum Level with SARS-CoV-2 Infection

Shimaa R Hendawy  1 , Heba Wagih Abdelwahab  2 , Mohammed A Hegazy  1 , Ahmed Mamdouh Elbeltagy  1 , Sherihan I Gouda  1 , Amr Mohamed El-Sabbagh  1 , Shaker Wagih Shaltout  3
Affiliations

Association of IL-17F Gene Polymorphism and Its Serum Level with SARS-CoV-2 Infection

Shimaa R Hendawy et al. Thorac Res Pract. 2023 Jul.

Abstract

Objective: Although multiple studies have addressed the clinical outcomes of coronavirus disease, little data exist regarding the defi- nition of immune and inflammatory profiles associated with this infection. Its clinical manifestations often worsen in association with hypercytokinemia (elevated interleukin 8 and interleukin 17). We conducted this research to elucidate the effect of interleukin 17 levels and interleukin 17F gene polymorphism on the severity and outcomes of coronavirus disease.

Material and methods: Ninety patients with confirmed coronavirus disease and 30 healthy controls were enrolled. Coronavirus disease cases were classified into nonsevere, severe, and critical according to the World Health Organization definition. Approximately 10 mL peripheral blood sample was collected from all patients and controls by venipuncture in-plane and ethylenediaminetetraacetic acid tube. Enzyme-linked immunosorbent assay kits were used for calculating serum interleukin 17 levels, whereas real-time polymerase chain reaction was used for genotyping using the 5'-nuclease allelic discrimination assay for single nucleotide polymorphisms genotyping.

Results: As regards interleukin 17 levels, there was a significant elevation of interleukin 17 in coronavirus disease cases compared to control healthy persons (P < .001). Moreover, serum interleukin 17 levels tended to be significantly higher with increased disease sever- ity (P = .004). Patients with critical diseases expressed a significant rise of interleukin 17 compared to severe (P = .03) and nonsevere cases (P = .02). We noted no significant difference between the critical, severe, and nonsevere cases regarding different interleukin 17F genotypes.

Conclusion: Coronavirus disease is associated with elevated levels of interleukin 17, which tended to be considerably higher with disease severity. However, different interleukin 17F genotypes do not affect either the predisposition or the severity of coronavirus disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Real-time fluorescence curves of real-time PCR assay targeting analysis for IL-17F rs6505162.
Figure 2.
Figure 2.
IL-17 levels (ng/L) in COVID-19 patients and control.
Figure 3.
Figure 3.
ROC analysis to identify the optimal IL-17 level for the prediction of COVID-19.
See this image and copyright information in PMC

References

    1. Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269 270. ( 10.1038/s41577-020-0308-3) - DOI - PMC - PubMed
    1. Song JW, Zhang C, Fan X, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020;11(1):3410. ( 10.1038/s41467-020-17240-2) - DOI - PMC - PubMed
    1. Shibabaw T. Inflammatory cytokine: il-17A signaling pathway in patients present with COVID-19 and current treatment strategy. J Inflamm Res. 2020;13:673 680. ( 10.2147/JIR.S278335) - DOI - PMC - PubMed
    1. Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53(3):368 370. ( 10.1016/j.jmii.2020.03.005) - DOI - PMC - PubMed
    1. Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250 256. ( 10.1002/jmv.26232) - DOI - PMC - PubMed

LinkOut - more resources